NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

醫藥品原料藥 (API)的全球市場 - 中國、印度市場集中的分析:考察、預測,新型冠狀病毒感染疾病 (COVID-19)的潛在影響 (2020年∼2024年)

Global Active Pharmaceutical Ingredient (API) Market with Focus on China & India: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版商 Koncept Analytics 商品編碼 977689
出版日期 內容資訊 英文 108 Pages
訂單完成後即時交付
價格
醫藥品原料藥 (API)的全球市場 - 中國、印度市場集中的分析:考察、預測,新型冠狀病毒感染疾病 (COVID-19)的潛在影響 (2020年∼2024年) Global Active Pharmaceutical Ingredient (API) Market with Focus on China & India: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
出版日期: 2020年12月16日內容資訊: 英文 108 Pages
簡介

全球醫藥品原料藥 (API)的市場規模,預計2020∼2024年以6.5%的年複合成長率成長,2024年達到2708億3000萬美元。尤其是進入2020年,受到新型冠狀病毒感染疾病 (COVID-19)的影響各國政府實施微干預,產生外部業者的內部認證的加速化,及供應鏈維持的國內生產體制強化的動向,對市場產生積極的影響。從各國來看,中國以豐富的資本和資源,材料費、人事費用低,比較和緩的法規為背景,急速成長。

本報告提供全球醫藥品原料藥 (API) 市場相關分析,整體市場規模趨勢預測 (過去、今後5年份) ,及各領域、各治療領域、各製造商類型及各地區詳細趨勢,中國、印度市場詳細分析,主要的推動及阻礙市場要素,企業間的競爭狀態、業績比較,主要企業簡介等調查。

目錄

第1章 市場概要

  • 簡介
  • API的分類
  • API的廠商
  • API的製造流程
  • API的供應鏈

第2章 新型冠狀病毒感染疾病 (COVID-19)的影響

  • 概要
  • 主要的API的供給趨勢分析
  • 中國的API市場
  • 印度的API市場

第3章 全球API市場分析

  • 市場規模 (以金額為準)
  • 市場規模,預測值 (以金額為準)
  • 市場規模:各領域
    • 小分子API
    • 生技藥品API
  • 市場規模:各治療領域
  • 市場規模:各製造廠商
  • 各治療領域的全球API市場價值
  • 各製造廠商的全球API市場價值
    • 自家公司用API
    • 銷售用API
    • 非專利(銷售用)API
    • 自訂合成(銷售用)API

第4章 API市場:各地區的分析

  • 中國
    • 市場規模 (以金額為準)
    • 市場規模,預測值 (以金額為準)
    • 出口額:各類型
    • 出口額:各國
  • 印度
    • 市場規模 (以金額為準)
    • 市場規模,預測值 (以金額為準)
    • 出口額:各類型
    • 出口額:各類型
    • 出口額:各國
    • 進口額:各類型
    • 進口額:各國

第5章 市場動態

  • 成長促進因素
    • 老年人口增加
    • 一待人接物的態度ta的醫療費的增加
    • 癌症患者的增加
    • 罕見疾病用醫藥品的產業的比重擴大
    • API醫藥品的外包的加速
  • 主要趨勢和動靜
    • 醫藥品的研究開發費增加
    • 藥物研發的人工智慧普及
    • API合成進步
    • 中國政府發表API相關的環境保護政策
  • 課題
    • 法規遵守

第6章 競爭情形

  • 全球API市場
    • 市場收益額比較:主要企業間
    • 股票市值比較:主要企業間
    • 研究開發費比較:主要企業間
  • 中國的API市場
  • 印度的API市場

第7章 企業簡介

  • Roche Holding AG
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Teva Pharmaceutical Industries Limited
目錄

The global API market is forecasted to reach US$270.83 billion in 2024, growing at a CAGR of 6.5% for the period spanning 2020-2024. The factors such as increasing ageing population, rising healthcare expenditure per capita, growing cancer patients, inclining orphan drugs industry and accelerating outsourcing of API drugs are expected to drive the market. However, growth of the industry would be challenged by regulatory compliance. Few notable trends include growth in pharmaceutical R&D expenditures, growing artificial intelligence (AI) adoption for drug discovery, advancement in API synthesis and announcement of environmental protection policies on APIs by China.

In 2020, the outbreak of COVID-19 pandemic has created a favorable impact on the market as many nations have been continuously making micro-interventions, speeding up internal certification for third party sources and as well as ramping up domestic production to keep supply chains functional as best as can be done.

APIs are available in different types in the market. On the basis of available source, the categories include small molecule (chemical) and biological (large molecule).

The fastest growing regional market is China owing to abundance of capital and other resources, low material costs and wage rates along with relatively relax regulations.

Scope of the report:

  • The report provides a comprehensive analysis of the global API market, segmented by synthesis (biological & small molecule) and manufacturers (captive & merchant).
  • The major regional markets (China and India) have been analysed.
  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Pfizer Inc., Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb Company and Teva Pharmaceutical Industries Limited) are also presented in detail.

Key Target Audience:

  • API Manufacturers
  • Raw Material Suppliers
  • End Users
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Classification of API
  • 1.3 Manufacturers of API
  • 1.4 Manufacturing Process of API
  • 1.5 Supply Chain of API

2. Impact of COVID-19

  • 2.1 Overview
  • 2.2 Supply Assessment of Major APIs
  • 2.3 China API Market
  • 2.4 India API Market

3. Global API Market Analysis

  • 3.1 Global API Market Value
  • 3.2 Global API Market Value Forecast
  • 3.3 Global API Market Value by Segments
    • 3.3.1 Global Small Molecule API Market Value
    • 3.3.2 Global Small Molecule API Market Value Forecast
    • 3.3.3 Global Biological API Market Value
    • 3.3.4 Global Biological API Market Value Forecast
  • 3.4 Global API Market Value by Therapeutic Areas
  • 3.5 Global API Market Value by Manufacturers
    • 3.5.1 Global Captive API Market Value
    • 3.5.2 Global Captive API Market Value Forecast
    • 3.5.3 Global Merchant API Market Value
    • 3.5.4 Global Merchant API Market Value Forecast
    • 3.5.5 Global Merchant API Market Value by Segments
    • 3.5.6 Global Generics (Merchant) API Market Value
    • 3.5.7 Global Generics (Merchant) API Market Value Forecast
    • 3.5.8 Global Custom Synthesis (Merchant) API Market Value
    • 3.5.9 Global Custom Synthesis (Merchant) API Market Value Forecast
    • 3.5.10 Global Merchant API Market Value by Region

4. Regional API Market Analysis

  • 4.1 China
    • 4.1.1 China API Market Value
    • 4.1.2 China API Market Value Forecast
    • 4.1.3 China API Exports by Types
    • 4.1.4 China API Exports by Country
  • 4.2 India
    • 4.2.1 India API Market Value
    • 4.2.2 India API Market Value Forecast
    • 4.2.3 India API Exports
    • 4.2.4 India API Exports by Types
    • 4.2.5 India API Exports by Country
    • 4.2.6 India API Imports
    • 4.2.7 India API Imports by Country

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Ageing Population
    • 5.1.2 Rising Healthcare Expenditure per Capita
    • 5.1.3 Growing Cancer Patients
    • 5.1.4 Inclining Orphan Drugs Industry
    • 5.1.5 Accelerating Outsourcing of API Drugs
  • 5.2 Key Trends and Developments
    • 5.2.1 Growth in Pharmaceutical R&D Expenditures
    • 5.2.2 Growing Artificial Intelligence (AI) Adoption for Drug Discovery
    • 5.2.3 Advancement in API Synthesis
    • 5.2.4 Announcement of Environmental Protection Policies on APIs by China
  • 5.3 Challenges
    • 5.3.1 Regulatory Compliance

6. Competitive Landscape

  • 6.1 Global API Market
    • 6.1.1 Key Players - Revenues Comparison
    • 6.1.2 Key Players - Market Cap Comparison
    • 6.1.3 Key Players - R&D Expenditures Comparison
  • 6.2 China API Market
  • 6.3 India API Market

7. Company Profiles

  • 7.1 Roche Holding AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Pfizer Inc.
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Novartis AG
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Merck & Co., Inc.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Bristol-Myers Squibb Company
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 Teva Pharmaceutical Industries Limited
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies

List of Figures

  • Classification of API
  • Chemical API Manufacturing Process
  • Biological API Manufacturing Process
  • Supply Chain of API
  • Global API Market Value (2015-2019)
  • Global API Market Value Forecast (2020-2024)
  • Global API Market Value by Segments (2019)
  • Global Small Molecule API Market Value (2015-2019)
  • Global Small Molecule API Market Value Forecast (2020-2024)
  • Global Biological API Market Value (2015-2019)
  • Global Biological API Market Value Forecast (2020-2024)
  • Global API Market Value by Therapeutic Areas (2019)
  • Global API Market Value by Manufacturers (2019)
  • Global Captive API Market Value (2015-2019)
  • Global Captive API Market Value Forecast (2020-2024)
  • Global Merchant API Market Value (2015-2019)
  • Global Merchant API Market Value Forecast (2020-2024)
  • Global Merchant API Market Value by Segments (2019)
  • Global Generics (Merchant) API Market Value (2015-2019)
  • Global Generics (Merchant) API Market Value Forecast (2020-2024)
  • Global Custom Synthesis (Merchant) API Market Value (2015-2019)
  • Global Custom Synthesis (Merchant) API Market Value Forecast (2020-2024)
  • Global Merchant API Market Value by Region (2019)
  • China API Market Value (2015-2019)
  • China API Market Value Forecast (2020-2024)
  • China API Exports by Types (2019)
  • China API Exports by Country (2019)
  • India API Market Value (2015-2019)
  • India API Market Value Forecast (2020-2024)
  • India API Exports (2015-2019)
  • India API Exports by Types (2019)
  • India API Exports by Country (2019)
  • India API Imports (2015-2019)
  • India API Imports by Country (2019)
  • Global Ageing Population (2015-2019)
  • Global Healthcare Expenditure per Capita (2015-2019)
  • Global Cancer Population (2015-2020)
  • Global Orphan Drugs Industry (2015-2019)
  • Global Pharmaceutical R&D Expenditures (2015-2019)
  • Key Players - Market Cap Comparison
  • Key Players - R&D Expenditures Comparison (2018/2019)
  • Roche Sales and Net Income (2015-2019)
  • Roche Sales by Segments (2019)
  • Roche Sales by Region (2019)
  • Pfizer Revenues and Net Income (2015-2019)
  • Pfizer Revenues by Segments (2019)
  • Pfizer Revenues by Region (2019)
  • Novartis Net Sales and Net Income (2015-2019)
  • Novartis Net Sales by Segments (2019)
  • Novartis Net Sales by Region (2019)
  • Merck Sales and Net Income (2015-2019)
  • Merck Sales by Segments (2019)
  • Bristol-Myers Revenues and Net Earnings (2015-2019)
  • Teva Net Revenues and Net Income (Loss) (2015-2019)
  • Teva Net Revenues by Region (2019)

List of Tables

  • China API Key Players Performance (2Q-2020)
  • India - Top APIs Imports from China (2020)
  • China Environmental Protection Policies on APIs (2015-2019)
  • Key Players - Revenues Comparison (2019)